Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmaNet Development Group | Contract Pharma
Breaking News, Promotions & Moves

PharmaNet Development Group

Marc Kamin, M.D., has been appointed vice president, Medical and Scientific Affairs, Neuroscience, PharmaNet Development Group.

Marc Kamin, M.D., has been appointed vice president, Medical and Scientific Affairs, Neuroscience, PharmaNet Development Group. Dr. Kamin will advise clients in the area of neuroscience and will provide medical support to PharmaNet project teams conducting neuroscience clinical studies.

Dr. Kamin is a neurologist, certified by the American Board of Psychiatry and Neurology, and has 20 years of experience in the pharmaceutical industry. Most recently, he led the Central Trial Coordination group for Medical Affairs in Global Clinical Operations at Johnson & Johnson. Dr. Kamin has designed and managed trials in many areas of neuroscience including migraine, eating disorders, bipolar disorder, alcohol addiction, acute and chronic pain, multiple sclerosis, epilepsy, peripheral neuropathy, amyotrophic lateral sclerosis and fibromyalgia.

“We are delighted to have a physician of his caliber at the forefront of our neuroscience team,” commented Dr. Pablo Fernandez, senior vice president, Worldwide Medical Affairs. “Marc’s vast experience and valuable expertise strengthens our neuroscience service offering.”


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters